Risk factors associated to kidney stones in primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 28, Issue 4, 2005, Pages 122-128

  Corbetta, S ^a,b   Baccarelli, A ^c   Aroldi, A ^b   Vicentini, L ^b   Fogazzi, G B ^b   Eller Vainicher, C ^a   Ponticelli, C ^b   Beck Peccoz, P ^a   Spada, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hypercalciuria; Nephrolithiasis; Oxaluria; Primary hyperparathyroidism

Indexed keywords

CALCIUM OXALATE; CITRIC ACID; MAGNESIUM; PARATHYROID HORMONE; CALCIUM; COLECALCIFEROL; OXALIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CALCIUM URINE LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCALCIURIA; MAGNESIUM URINE LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; RISK FACTOR; STONE FORMATION; URINALYSIS; URINARY EXCRETION; URINE SEDIMENT; BLOOD; HOSPITALIZATION; HYPERPARATHYROIDISM; KIDNEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

AGED; CALCIUM; CALCIUM OXALATE; CHOLECALCIFEROL; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY; KIDNEY CALCULI; MALE; MIDDLE AGED; OXALATES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 20444450575     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345354     Document Type: Article

References (33)

1. Chan AK, Duh Q-Y, Katz MH, et al. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. Ann Surg 1995, 222: 402-14.
2. Silverberg SJ, Shane E, Jacobs TP, et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990, 89: 327-34.
3. Söreide JA, van Heerden JA, Grant CS, Lo CY, Ilstrup DM. Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones. Surgery 1996, 120: 1033-7.
4. Udèn P, Chan A, Duh Q-Y, et al. Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg 1992, 16: 791-8.
5. Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD. Primary hyperparathyroidism: a prospective clinical study. Am J Med 1971, 50: 670-8.
6. Broadus A. Nephrolithiasis in primary hyperparathyroidism. In: Coe F, Brenner B, Stein J eds. Nephrolithiasis. New York: Chirchill Livingstone. 1980.
7. Pak CY, Nicar MJ, Peterson R, Zerwekh JE, Snyder W. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 1981, 53: 536-42.
8. Kristoffersson A, Backman C, Granqvist K, Jarhult J. Pre- and postoperative evaluation of renal function with five different tests in patients with primary hyperparathyroidism. J Int Med 1990, 227: 317-24.
9. Sutton RA, Watson L. Urinary excretion of calcium and magnesium in primary hyperparathyroidism. Lancet 1969, 1: 1000-3.
10. Johannson G, Danielson BG, Ljunghall S. Magnesium homeostasis in mild to moderate primary hyperparathyroidism. Acta Chirur Scand 1980, 146: 85-91.
11. Alvarez-Arroyo MV, Traba ML, Rapado A, de la Piedra C. Role of citric acid in primary hyperparathyroidism with renal lithiasis. Urol Res 1992, 20: 88-90.
12. Lonsdale K. Human stones. Science 1968, 159: 1199-207.
13. Pak CYC, Holt K, Zerwekh JK. Attenuation by sodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest Urol 1979, 17: 138-41.
14. Ljunghall S, Akerstrom G. Urate metabolism in primary hyperparathyroidism. Urol Intern 1982, 37: 73-8.
15. Baumann JM, Lauber K, Lustenberger FX, Wacker M, Zingg EJ. Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism. Urol Res 1985, 13: 169-74.
16. Atmani F, Khan SR. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone forming patients. Urol Intern 2002, 68: 54-9.
17. Broulek PD, Stepan JJ, Pacovsky V. Primary hyperparathyroidism and hyperuricemia are associated but not correlated with indicators of bone turnovers. Clin Chim Acta 1987, 170: 195-200.
18. nd ed. Oxford: Oxford University Press. 1999: 13-28.
19. Fogazzi GB, Ponticelli C. Microscopic haematuria, diagnosis and management. Nephron 1996, 72: 125-34.
20. Sutton RA, Walker VR. Enteric and mild hyperoxaluria. Min Electrolyte Metab 1994, 20: 352-60.
21. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Min Res 1991, Suppl 2: S85-89.
22. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Eng J Med 1999, 341: 1249-55.
23. Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stones events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. Br Med J 2002, 325: 807-11.
24. Coe FL, Parks JL, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992, 327: 1141-52.
25. Frøkjaer VG, Mollerup CL. Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy. World J Surg 2002, 26: 532-5.
26. Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med 1980, 302: 421-6.
27. Patron P, Gardin JP, Poullard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 1987, 31: 1176-80.
28. Marengo SR, Chen DH, MacLennan GT, Resnick MI, Jacobs GH. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. J Urol 2004, 171: 1304-8.
29. Bilezikian JP, Potts JT, Fuleihan GE, et al. Summary Statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002, 87: 5353-61.
30. Giannini S, Nobile M, Castrignano R, et al. Possibile link between vitamin D and hyperoxaluria in patients with renal stone disease. Clin Sci (London) 1993, 84: 51-4.
31. Krishnamurthy MS, Hruska KA, Chandhoke PS. The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 2003, 169: 2030-3.
32. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 2003, 44: 475-81.
33. Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 2003, 8: e437-43.